Concepedia

Author

Amy Rosado

Pfizer (United States)

Also Known As

A Rosado, Acela Cristina Rosado, Amy L. Rosado, Amy Rosado

14

Publications

336

Citations

8

H-Index

38

Concepts

All Affiliations

Pfizer (United States)Nemours Children's ClinicUniversity of Central Florida
AR

About

Amy Rosado is an author at Pfizer (United States) specializing in medicine, drug discovery, and molecular modeling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

161

2

Cell Biology

2

2

109

3

Health Sciences

1

1

36

4

Natural Sciences

1

1

16

5

Biochemistry

1

1

16

Amy Rosado

×

8

Publications

336

Citations

8

H-Index

YearCitations

Nanoparticle delivery of curcumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2/Bax in human neuroblastoma

Irina Kalashnikova, Joseph Mazar, Craig J. Neal,

Nanoscale

2017

102

The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma

Joseph Mazar, Amy Rosado, John P. Shelley,

Oncotarget

2016

66

Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24

Joseph Mazar, Yujia Li, Amy Rosado,

PLoS ONE

2018

43

Casein Kinase 1δ/ε Inhibitor PF-5006739 Attenuates Opioid Drug-Seeking Behavior

Travis T. Wager, Ramalakshmi Y. Chandrasekaran, Jenifer A. Bradley,

ACS Chemical Neuroscience

2014

36

BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice

Eliza Bollinger, Matthew Peloquin, Jenna Libera,

Molecular Metabolism

2022

36

Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levels

Rachel J. Roth Flach, Eliza Bollinger, Allan R. Reyes,

Nature Communications

2023

27

Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors

Shenping Liu, Bethany L. Kormos, John D. Knafels,

Journal of Biological Chemistry

2023

16

Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948

Kevin J. Filipski, Luis Martinez-Alsina, Matthew R. Reese,

Journal of Medicinal Chemistry

2024

10

Page 1